Total Payments
$271,640
2024 Payments
$10,851
Companies
27
Transactions
515
Medicare Patients
4,971
Medicare Billing
$547,062
Payment Breakdown by Category
Other$237,552 (87.5%)
Food & Beverage$14,047 (5.2%)
Travel$12,304 (4.5%)
Consulting$7,563 (2.8%)
Education$173.57 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $237,553 | 121 | 87.5% |
| Food and Beverage | $14,047 | 312 | 5.2% |
| Travel and Lodging | $12,304 | 58 | 4.5% |
| Consulting Fee | $7,563 | 10 | 2.8% |
| Education | $173.57 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $128,309 | 162 | $0 (2024) |
| Lilly USA, LLC | $57,261 | 75 | $0 (2024) |
| PFIZER INC. | $35,821 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $32,996 | 38 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $7,763 | 11 | $0 (2024) |
| Abbott Laboratories | $4,267 | 92 | $0 (2024) |
| Boston Scientific Corporation | $1,454 | 20 | $0 (2024) |
| Terumo Medical Corporation | $989.93 | 9 | $0 (2024) |
| Amgen Inc. | $561.16 | 16 | $0 (2023) |
| ABIOMED | $495.51 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,851 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,248) |
| 2023 | $36,584 | 77 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,485) |
| 2022 | $35,579 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26,892) |
| 2021 | $48,873 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30,740) |
| 2020 | $20,985 | 35 | Lilly USA, LLC ($10,634) |
| 2019 | $48,468 | 98 | Lilly USA, LLC ($20,539) |
| 2018 | $31,083 | 81 | E.R. Squibb & Sons, L.L.C. ($11,210) |
| 2017 | $39,216 | 64 | E.R. Squibb & Sons, L.L.C. ($21,661) |
All Payment Transactions
515 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ROTAPRO_IC | ||||||
| 09/17/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $57.81 | General |
| Category: DEVICES | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $139.69 | General |
| Category: AVVIGO_IC | ||||||
| 09/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: General - Structural Heart_IC | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $36.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/09/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Vascular | ||||||
| 07/26/2024 | Terumo Medical Corporation | GLIDEWIRE (Device), HEARTRAIL, METACROSS OTW | Food and Beverage | In-kind items and services | $46.39 | General |
| Category: LESION ACCESS | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $37.52 | General |
| Category: DIABETES | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $52.93 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: DIABETES | ||||||
| 06/06/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,304 | 1,491 | $511,600 | $128,219 |
| 2022 | 24 | 1,164 | 1,440 | $524,933 | $135,167 |
| 2021 | 24 | 1,206 | 1,438 | $532,054 | $137,255 |
| 2020 | 26 | 1,297 | 1,409 | $621,161 | $146,421 |
Total Patients
4,971
Total Services
5,778
Medicare Billing
$547,062
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 4 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92933 | Removal of plaque and insertion of stent in major coronary artery or branch, accessed through the skin | Facility | 2020 | 16 | 17 | $37,842 | $8,791 | 23.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 54 | 64 | $14,336 | $6,412 | 44.7% |
| 93459 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 26 | 26 | $32,422 | $6,222 | 19.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $9,435 | $4,183 | 44.3% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2020 | 280 | 285 | $12,255 | $2,787 | 22.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $4,455 | $2,417 | 54.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 24 | 27 | $4,050 | $2,170 | 53.6% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft | Facility | 2020 | 29 | 29 | $8,439 | $2,167 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 37 | $3,885 | $2,145 | 55.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 36 | $3,528 | $1,768 | 50.1% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2020 | 31 | 31 | $15,996 | $1,695 | 10.6% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 21 | 28 | $4,116 | $1,528 | 37.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 19 | $3,895 | $1,525 | 39.2% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2020 | 33 | 62 | $7,688 | $1,512 | 19.7% |
| 93296 | Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days | Office | 2020 | 32 | 61 | $7,198 | $1,169 | 16.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 14 | $1,946 | $704.50 | 36.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 26 | 27 | $2,349 | $355.63 | 15.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 24 | 24 | $1,968 | $303.56 | 15.4% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 31 | 31 | $1,674 | $285.60 | 17.1% |
| 93922 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 17 | 17 | $2,174 | $217.69 | 10.0% |
| 93270 | Heart rhythm symptom-related tracing of 24-hour ekg monitoring up to 30 days | Office | 2020 | 11 | 11 | $1,738 | $73.77 | 4.2% |
About Dr. Jan Pattanayak, MD
Dr. Jan Pattanayak, MD is a Interventional Cardiology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699860338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Pattanayak, MD has received a total of $271,640 in payments from pharmaceutical and medical device companies, with $10,851 received in 2024. These payments were reported across 515 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($237,553).
As a Medicare-enrolled provider, Pattanayak has provided services to 4,971 Medicare beneficiaries, totaling 5,778 services with total Medicare billing of $547,062. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Asheville, NC
- Active Since 10/04/2006
- Last Updated 01/25/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1699860338
Products in Payments
- JARDIANCE (Drug) $184,628
- ELIQUIS (Drug) $68,552
- XARELTO (Drug) $7,763
- OPTIS (Device) $2,140
- Optis Coronary Imaging System (Device) $689.78
- Repatha (Biological) $546.23
- Impella (Device) $495.51
- ROTABLATOR (Device) $390.98
- Xience V coronary stent system (Device) $316.32
- Xience Alpine cornary stent system (Device) $264.66
- AVVIGO Guidance System (Device) $254.91
- Navicross (Device) $234.70
- Xience Sierra Coronary Stent System (Device) $208.88
- GENERAL ATHERECTOMY (Device) $191.58
- PCI Optimization (Device) $188.21
- Diamondback Coronary (Device) $187.95
- SYMPLICITY G3 (Device) $153.27
- CROSSBOSS (Device) $146.82
- VYNDAQEL (Drug) $134.18
- Asahi Fielder coronary guide wire (Device) $132.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Asheville
Dr. John Lawrence, M.d, M.D
Interventional Cardiology — Payments: $231.65
Interventional Cardiology $231.65
Dr. William Maddox, M.d, M.D
Interventional Cardiology — Payments: $107.55
Interventional Cardiology $107.55
Dr. David Serfas, M.d, M.D
Interventional Cardiology — Payments: $75.90
Interventional Cardiology $75.90